Varamir
Desk
News
Calendar
Pricing
Saved
Search
tickers or companies
⌘K
Start free
· no card
Sign in
AMGN compared with MRNA: revenue, margins and what each company keeps, and the suppliers and customers both name
AMGN
Amgen Inc
Change
Mkt cap
Revenue
Revenue
MRNA
Moderna, Inc.
Change
Mkt cap
Revenue
Revenue
vs
Compare
AMGN
Amgen Inc
vs
MRNA
Moderna, Inc.
Price
Mkt cap
Revenue
Revenue
Change
Change
Revenue flow
Supply chain
Price
Co-movers
Event sensitivity
Earnings history
Save comparison
Copy link
Earnings history
Desk
News
Calendar
Saved
Search
Earnings history
last 4 reports each · paired by recency
Method
›
AMGN
4 of 4
at or beyond implied
Report
implied
realized
× implied
Q2 FY26
±4.1%
▲
+4.57%
×1.12
Q1 FY26
±3.9%
▼
−4.75%
×1.23
Feb 4 '26
±3.7%
▲
+8.15%
×2.22
Q3 FY25
±3.7%
▲
+7.81%
×2.11
MRNA
0 of 4
at or beyond implied
Report
implied
realized
× implied
Q2 FY26
±9.8%
▼
−5.35%
×0.54
Q1 FY26
±6.9%
▼
−1.24%
×0.17
= implied
AMGN realized, solid
MRNA realized, hatched
One scale, both sides: full bar = 10%
× = |realized| ÷ implied
Source: market data
Feb 13 '26
±7.7%
▲
+5.29%
×0.69
Jan 12 '26
±7.6%
▼
−1.34%
×0.17
AMGN
Amgen Inc
Change
465.45
▼
−0.12%
· post 466.36
Mkt cap
$251.6B
Revenue
$10.1B
Q2 FY26
Revenue
$36.8B
FY25
MRNA
Moderna, Inc.
Change
220.15
▼
−0.71%
· post 220.50
Closed
Nov 2 '26
Mkt cap
$88.5B
Revenue
$145M
Q2 FY26
Revenue
$1.9B
FY25
vs
Compare
Closed
Nov 2 '26
AMGN
Amgen Inc
vs
MRNA
Moderna, Inc.
465.45
▼
−0.12%
post 466.36
Price
220.15
▼
−0.71%
post 220.50
$251.6B
Mkt cap
$88.5B
Q2 FY26
$10.1B
Revenue
$145M
Q2 FY26
FY25
$36.8B
Revenue
$1.9B
FY25
Change
Change
AMGN
465.45
▼
−0.12%
vs
MRNA
220.15
▼
−0.71%
Closed
Nov 2 '26